Albumin & Creatinine Tests Market Size & Share, by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents); Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin); End-user (Hospital, Diagnostic & Research Labs) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4665
  • Published Date: Jan 30, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Albumin & Creatinine Tests Market size is projected to surpass USD 19 billion by the end of 2035, witnessing around 19% CAGR during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of albumin & creatinine tests was USD 3 billion. The growth of the market can be attributed to the increasing cases of kidney diseases and disorders worldwide. Kidney disease is a serious medical condition that can lead to kidney failure. As per the Centers for Disease Control and Prevention (CDC), more than 1 in 7 adults i.e., 37 million people, suffered from chronic kidney disease in 2021. A variety of urine analysis procedures and products are available to detect such disease, which include multiple kidney treatments as well as regular blood examinations of components such as creatinine, albumin, and the ACR ratio. Urine analysis can provide information about the presence of kidney diseases. It can also help to monitor the progression of kidney diseases and assess the effectiveness of treatment.

Additionally, other factors that are anticipated to contribute to the growth of the global albumin tests and creatinine tests market include the increasing awareness of early disease detection among people and the growing preference for home testing for regular monitoring. Additionally, innovations in urine analysis testing is anticipated to contribute to the growth of the market. For instance, Minuteful Kidney is a smartphone-based, home kidney function testing service that is convenient and affordable. The test is easy to use and can be done at home without visiting a doctor. It can be done regularly to help people with diabetes or high blood pressure monitor their kidney health. The result of the patient's test is automatically recorded in the app's electronic medical record, and it is automatically sent to their healthcare practitioner for further action.

Albumin-Tests-Market -Creatinin-Tests Market-overview
Get more information on this report: Request Free Sample PDF

Albumin & Creatinine Tests Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Rates of Hypoalbuminemia and Hypovolemia – Hypoalbuminemia is one of the major factors associated with acute pancreatitis, and it is estimated that hypoalbuminemia affects 30% of patients with acute pancreatitis. In addition, low albumin levels are directly linked to an increased risk of severity and mortality associated with the condition. Thus, the level of serum albumin in the blood must be continually monitored. A continuous and frequent albumin test is required to monitor serum albumin levels. Hence, these factors are anticipated to lead to positive growth in the market.

  • Increasing Prevalence of Chronic Disease Conditions – The prevalence of chronic diseases leads to various kidney disorders, whose severity is assessed by two laboratory tests including creatinine levels and albumin levels in the urine. According to the World Health Organization, approximately 41 million people die every year from chronic diseases across the world, which accounts for 74% of all global deaths.

  • Rising Expenditure on Life Science and Medical Research – The United States Government spent more than USD 3 billion in 2019 on health research and development, with the global export value of medical technology products from the UK being nearly USD 5 billion in 2020. Rising expenditure on life science and medical research is creating opportunities for companies that provide integrated systems for albumin and creatinine tests. Increased funding for medical research is expected to drive the market’s growth.

  • Fast Growth in the Field of Diagnostics and Increasing Demand for Easy-to-use Kits – In India, the National Accreditation Board of Laboratories increased from 500 in 2015 to 1200 in 2020, which accounts for approximately 1% of total labs in India, as per the estimations. The number of accredited laboratories in various regions has increased rapidly in recent years, owing to the increasing demand for easy-to-use diagnostic kits.

  • Growing Geriatric Population and Increasing Practice of Sedentary Lifestyle – As per the World Health Organization, the worldwide old age population is estimated to double and reach 2.1 billion by 2050, from a base of 1 billion in 2020. The geriatric population is more susceptible to chronic diseases such as kidney disease. The sedentary lifestyle of this population group leads to further complications and health risks.


  • Increased Price of an Automated Analyzer - Automatic analyzers analyze blood samples automatically and provide results within minutes. However, these machines are very expensive and require a great deal of maintenance. Therefore, many hospitals and clinics are unable to afford such devices and prefer to use semi-automated devices. The consequent impact on the adoption rate in developing countries with a large number of small hospitals is expected to hinder the market's growth.
  • Lack of Accuracy of the Test
  • Diagnostic and Analytical Difficulties with Urine Samples in Chronically Ill Individuals

Albumin & Creatinine Tests Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 3 Billion

Forecast Year Market Size (2035)

~ USD 19 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Albumin & Creatinine Tests Segmentation

Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin)

The global albumin & creatinine tests market is segmented and analyzed for demand and supply by type into blood & urine creatinine, urine albumin, and glycated albumin. Out of these, the urine albumin segment is estimated to gain the largest market share over the projected time frame. Albuminuria (urine albumin) is a sign of kidney disease and is characterized by excessive albumin levels in the urine. It has been observed that the proportion of patients who have urine albumin laboratory results is increasing over time in every age group, along with the resulting increase in consumer demand for convenient and rapid urine tests, which is expected to drive segment growth throughout the forecast period. As a result of a survey conducted in the United States between 2005 and 2019, it was found that the percentage of people with urine albumin results increased from 6%–16% among 40–49-year-olds; 11%–22% among 50–59-year-olds, 12%–27% among 60-69-year-olds and 10%–25% for those older than 70.

Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents)

The global albumin & creatinine tests market is also segmented and analyzed for demand and supply by-product into analyzers, cartridges (POC, tabletop), dipsticks & kits, and reagents. Amongst these segments, the dipsticks & kits segment is expected to garner a significant share by the end of 2035. The albumin & creatinine tests are used to detect kidney damage, and the kits for these tests are becoming more popular as they are less expensive and easier to use than traditional analyzers and cartridges. Moreover, a urine dipstick test is a quick and easy way to test for the presence of various substances in the urine, such as protein, blood, and sugar. The results are usually available between 60 and 120 seconds after an appointment with the doctor. Therefore, such factors are expected to fuel the growth of the segment in the future.

Our in-depth analysis of the global market includes the following segments:

     By Product

  • Analyzers
  • Cartridges (PoC, Tabletop)
  • Dipsticks & Kits
  • Reagents

       By Type

  • Blood & Urine Creatinine
  • Urine Albumin
  • Glycated Albumin

       By End User

  • Hospital
  • Diagnostic & Research Labs

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Albumin & Creatinine Tests Industry - Regional Synopsis

North American Market Forecast   

The North American albumin tests market & creatinine tests market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. Growth in the regional market can be attributed primarily to the increasing prevalence of chronic diseases and the rise in healthcare spending by the general population. Furthermore, chronic diseases such as type 1 or type 2 diabetes, high blood pressure, and obesity can lead to kidney diseases. With the growing incidence of these diseases, rapid urine testing has become an increasingly crucial method of diagnosing kidney disorders. The prevalence of obesity, a chronic disease condition, in the U.S. from 2017 to 2020 rose from 30.5% to 41.9% and in the same period, the prevalence of severe obesity rose from 4.7% to 9.2%, as per the Centers for Disease Control and Prevention. Additionally, according to the same source, more than 37 million Americans suffer from diabetes, with approximately 90-95% having diabetes type 2 most commonly occurs in adults over 45.

Research Nester
Albumin and Creatinine Tests Market Trends
Get more information on this report: Request Free Sample PDF

Companies Dominating the Albumin & Creatinine Tests Landscape

    • RayBiotech Life, Inc.

      • Company Overview

      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Danaher Corporation
    • FUJIFILM Wako Pure Chemical Corporation
    • Nova Biomedical
    • Ortho Clinical Diagnostics
    • PromoCell GmbH
    • Siemens Healthineers company
    • Sysmex Corporation
    • Teco Diagnostics
    • Thermo Fisher Scientific Holdings, Inc.


In The News

  • Sysmex Corporation introduced a new product named as UF-1500 Fully Automated Urine Particle Analyzer (UF-1500). The UF-1500 is a new product that automates the process of testing urine sediments. This will allow for faster and more accurate results.

  • Siemens Healthcare GmbH declared the global OEM partnership to enhance patient monitoring with chronic kidney diseases. Using Healthy. Io's smartphone-based urinalysis system, the company's urinalysis reagents allow patients to conduct home testing

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4665
  • Published Date: Jan 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising rates of hypoalbuminemia and hypovolemia and the rising geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 19% over the forecast period, i.e., 2023-2035.

The increased price of the automated analyzer and the lack of accuracy of the test are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are RayBiotech Life, Inc., Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PromoCell GmbH, Siemens Healthineers, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Holdings, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, type, end-user, and by region.

The urine albumin segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Albumin & Creatinine Tests Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying